New agents for Gram-positive bacteria

This publication has 40 references indexed in Scilit:

• Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals
  Diagnostic Microbiology and Infectious Disease, 1999
• Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin
  Journal of Antimicrobial Chemotherapy, 1999
• The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
  Journal of Antimicrobial Chemotherapy, 1999
• Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme
  Journal of Antimicrobial Chemotherapy, 1999
• Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program
  Diagnostic Microbiology and Infectious Disease, 1999
• Penicillin- and Cephalosporin-Resistant Streptococcus Pneumoniae
  Drugs, 1999
• Quinupristin/Dalfopristin
  Drugs, 1999
• Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Quinupristin-Dalfopristin against Gram-Positive and -Negative Organisms
  Antimicrobial Agents and Chemotherapy, 1998
• Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
  Antimicrobial Agents and Chemotherapy, 1998
• Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients
  The American Journal of Medicine, 1996